LNTH · Lantheus Holdings, Inc. · Metrics
$100.61
-1.39 (-1.36%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Market Cap
$6.67B
Shares
65.40M
Volume · Nov 18
946.87K
Avg daily vol (3M)
1.04M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
LNTH metrics
105 of 125 screener metrics currently available.
Market overview
2 metricsShare price
$102.00
Market cap
$6.67B
Price action
23 metricsPrice change (1W)
+0.4%
Price change (30D)
+2.1%
Price change (3M)
+1.5%
Price change (6M)
+6.2%
Price change (YTD)
+53.3%
Price change (1Y)
+90.7%
Trailing year
Price change (5Y)
+252.2%
52-week high
$110.94
52-week low
$52.79
Change from 52-week high
-8.1%
Change from 52-week low
+93.2%
Annualized volatility
30.2%
Annualized volatility (3M)
4.2%
Implied volatility (30D)
10.8%
IV rank (1Y)
3.0
IV percentile (1Y)
3.4
Beta
0.5
RSI (14D)
67.9
Price vs SMA 50
+1.6%
Price vs SMA 200
+8.9%
Avg volume (3M)
1.04M
Relative volume
0.9
Average dollar volume
$104.16M
Company
3 metricsSector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Shares outstanding
65.40M
Valuation
12 metricsP / E (TTM)
24.9
Trailing earnings · reciprocal yield 4.0%
PEG ratio
—
EV / revenue
4.2×
reciprocal yield 23.8%
EV / EBITDA
17.2×
reciprocal yield 5.8%
EV / EBIT
22.5×
reciprocal yield 4.4%
P / sales
4.3×
reciprocal yield 23.4%
P / book
4.9
reciprocal yield 20.3%
FCF yield
—
TTM · current market cap
Buyback yield
1.5%
P / FCF
—
P / operating cash flow
16.3
reciprocal yield 6.1%
Earnings yield
4.0%
Historical valuation
8 metricsP / E historical average (3Y)
19.3×
reciprocal yield 5.2%
P / E historical average (5Y)
47.9×
reciprocal yield 2.1%
EV / revenue historical average (3Y)
3.6×
reciprocal yield 27.5%
EV / revenue historical average (5Y)
4.5×
reciprocal yield 22.0%
EV / EBIT historical average (3Y)
14.6×
reciprocal yield 6.9%
EV / EBIT historical average (5Y)
38.5×
reciprocal yield 2.6%
EV / EBITDA historical average (3Y)
12.1×
reciprocal yield 8.2%
EV / EBITDA historical average (5Y)
46.1×
reciprocal yield 2.2%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.5%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
2026-11-05
Profitability
9 metricsGross margin
61.3%
Operating margin
18.6%
Trailing 12 months
Net margin
17.3%
Gross profit (TTM)
$957.06M
Operating profit (TTM)
$290.93M
Net income (TTM)
$269.90M
Trailing 12 months
Diluted EPS (TTM)
$4.10
FCF margin
—
Effective tax rate
21.2%
Growth
11 metricsRevenue growth YoY
+1.5%
Year over year
Net income growth YoY
-19.4%
Revenue (TTM)
$1.56B
Trailing 12 months
EPS growth YoY
-19.5%
Shares change YoY
+1.1%
Year over year · more shares
Revenue CAGR (3Y)
+18.1%
Revenue CAGR (5Y)
+35.3%
EPS CAGR (3Y)
+104.3%
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
19.9%
Return on assets
11.0%
Debt / equity
0.4
Current ratio
3.2
EBITDA (TTM)
$381.93M
Free cash flow (TTM)
—
Quick ratio
3.1
Interest coverage
14.7
Net debt / EBITDA
-0.3
Return on invested capital
18.4%
Trailing 12 months
Net cash
$111.87M
Latest balance sheet
Cash & equivalents
$683.61M
Total assets
$2.46B
Total debt
$571.74M
Cash flow & spend
7 metricsOperating cash flow (TTM)
$409.48M
Capital expenditures (TTM)
—
R&D (TTM)
$217.82M
SG&A (TTM)
—
Stock compensation (TTM)
$75.47M
R&D / revenue
13.9%
Stock compensation / revenue
4.8%
Ownership (13F)
9 metrics13F filers
431
13F filer change QoQ
-40
Institutional ownership
99.2%
Conviction holders (share of 13F filers)
2.3%
Crowding (high-turnover and private-fund holders)
35.5%
Private-fund adviser ownership
34.1%
Active holders' share change QoQ
-13.1%
Holder tenure
13.6
Price vs estimated holder cost
+13.7%
Ownership (registered funds)
1 metricsIndex-fund ownership
23.8%
Short interest
3 metricsShort interest
5.6%
Latest settlement · 3.2 days to cover
Days to cover
3.2d
Short-squeeze score
67 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—
Key facts
CIK
1521036
CUSIP
516544103
13F (30d)
450 filings
402 filers
Visit website
Investor relations